Log In Sign Up

Trading

Trading

Browse Companies

Data

Data

IPO Stock Tracker

Solutions

Solutions

For Institutions

For Shareholders

Insights

Insights

Popular Topics

Buying Pre-IPO Shares

Selling Pre-IPO Shares

Private Market Reports

Private Market Data & Analytics

About

About

Investor Relations

People & Culture

CG Oncology Stock

cgoncology.comHealthcareFounded: 2010Funding to Date: $202.87MM

CG Oncology is a developer of genitally engineered oncolytic immunotherapy treatments for individuals with advanced cancer.

Buy or sell CG Oncology stock Learn more about CG Oncology IPO

Overview Financings Valuation

Enterprise Value (based on primary financings)

Enterprise Value

View Enterprise Value for CG Oncology.

Register Today

Other companies like CG Oncology in the Healthcare sector

Sector

Last Round Est. Valuation

$2.15B

Colossal Biosciences

Sector

Sector

Last Round Est. Valuation

$3.67B

Sector

Last Round Est. Valuation

$400.53MM

Sector

Last Round Est. Valuation

$4.26B

Sector

Sector

Mammoth Biosciences

Sector

Last Round Est. Valuation

$1.08B

Precision Neuroscience

Sector

News

Businesswire 11/21/2022

CG Oncology Raises $120 Million in Oversubscribed Series E Financing to Advance Clinical-Stage Urologic Oncology Pipeline

The Series E financing round, was co-led by ORI Capital, Longitude Capital and Decheng Capital, with participation from RA Capital Management, Acorn Bioventures, Malin Corporation, Ally Bridge Group and Sirona Capital.

Frequently Asked Questions